E2. Nigel Strauss – Psychedelic psychiatry in Australia

Stitcher_Listen_Badge_Color_Light_BG

US_UK_Apple_Podcasts_Listen_Badge_RGB

Today we speak with Dr. Nigel Strauss, a psychiatrist with over 40 years experience and Adjunct Professor at Deakin University.

Nigel’s career has focused on medico-legal psychiatry, in particular Post-Traumatic Stress Disorder (PTSD).  He is Director of Occupational Psychiatry Pty. Ltd. which integrates psychiatry into the workplace.

Prompted by the extraordinary results of MDMA-assisted psychotherapy in the treatment of PTSD (which was recently granted breakthrough therapy designation by the US FDA), Nigel became interested in the therapeutic potential of MDMA and other psychedelics, a stigmatised but therapeutically promising class of drugs.

Nigel now advocates for psychedelic-research in Australia and has published a number of papers on the subject.

Episode References

Millswyn Clinic – Nigel’s workplace

Multidisciplinary Association for Psychedelic Study

MDMA-assisted psychotherapy granted breakthrough therapy designation

Psylocibin-assisted psychotherapy granted breakthrough therapy designation

Nigel’s paper advocating for psychedelic research in Australia

Nigel’s paper on psilocybin-assisted therapy for terminally ill patients with anxiety and depression

Leave a Reply

Your email address will not be published.